tiprankstipranks
Trending News
More News >

Charmacy Pharmaceutical Announces AGM and Key Resolutions for 2025

Story Highlights
Charmacy Pharmaceutical Announces AGM and Key Resolutions for 2025

Confident Investing Starts Here:

Charmacy Pharmaceutical Co., Ltd. Class H ( (HK:2289) ) has shared an update.

Charmacy Pharmaceutical Co., Ltd. has announced its upcoming Annual General Meeting (AGM) scheduled for May 22, 2025, in Guangzhou City, China. The meeting will address several key resolutions, including the approval of the 2024 financial reports, amendments to meeting procedures, profit distribution plans, director remuneration, and the re-appointment of auditors. Additionally, the company plans to apply for a comprehensive revolving credit line of up to RMB 2.8 billion, which could significantly impact its financial flexibility and operational strategy.

More about Charmacy Pharmaceutical Co., Ltd. Class H

Charmacy Pharmaceutical Co., Ltd. is a joint stock limited liability company incorporated in China, operating in the pharmaceutical industry. The company is involved in the production and distribution of pharmaceutical products, focusing on the Chinese market.

YTD Price Performance: -20.92%

Average Trading Volume: 2,000

Technical Sentiment Signal: Buy

Current Market Cap: HK$837M

For an in-depth examination of 2289 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1